Published: 10 March 2024
Author(s): Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, Velia Cassano, Angela Sciacqua, Mohamad Khalil, Piero Portincasa, Leonilde Bonfrate
Issue: June 2024
Section: Review Article

Irritable bowel syndrome (IBS), a chronic functional gastrointestinal disorder, manifests through recurrent episodes of abdominal pain or discomfort, coupled with variations in bowel habits encompassing constipation, diarrhea, or a blend of both, without detectable organic abnormalities [1–3]. Clinical diagnosis typically adheres to the Rome IV criteria, categorizing the condition into four subtypes based on the patient's predominant bowel habit, as determined by the Bristol Stool Form Scale (i.e., predominant diarrhea [IBS-D], predominant constipation [IBS-C], mixed bowel habits [IBS-M], unclassified IBS [IBS-U]) [4–6].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.